Detailed Narrative
Q4 FY25 Performance Overview
Kaya Limited reported a 15% collection growth in its India clinics for Q4 FY25, with the product business growing 9%. The services segment saw a 16% collection growth, notably driven by Anti-Ageing (40% growth) and Body contouring (38% growth). Revenue from operations stood at INR 54.7 crores, marking a 3% increase over Q4 FY24, despite the company recording a standalone loss after tax of INR 7.1 crores, which included one-time📎 gains of INR 2.4 crores from noncurrent investment sale and INR 3 crores from IP rights sale.
Strategic Initiatives and Expansion Plans
The company is accelerating its expansion strategy, having opened 4 new clinics in FY25 and already signing 7 for FY26, with plans for more locations. A brand refresh program saw 13 clinics renovated and 7 relocated in FY25, and this program is set to continue into FY26. Additionally, Kaya invested in 9 new dermatology machines in Q4 FY25 to enhance service technology and customer experience, aiming for an NPS score of 89.
Path to Profitability and Fundraising
Management outlined a clear path to profitability, contingent on a forthcoming rights issue to raise funds in the 'not-too-distant future'. This fundraising is expected to enable the retirement of current loans, which would improve profitability by INR 18 crores annually due to reduced interest costs. The company aims to become net worth positive post-fundraising and leverage its existing head office infrastructure to achieve operating profitability with accelerated growth.
Revenue Dynamics and Customer Engagement
While net revenues saw a 6% QoQ decline, management clarified that collections are a lead indicator, and strong March collections (26% growth) are expected to translate into revenue in subsequent months as customers consume pre-purchased packages. The Kaya Smiles loyalty program contributed over 80% of clinic collections in Q4 FY25, demonstrating strong customer retention and engagement through experiential marketing for its Platinum and Gold Elite base.
Market Competition and Growth Outlook
The aesthetics market is growing at an estimated 17% annually, attracting significant local competition. Despite Kaya's Q4 growth of 15%, management expressed confidence in its brand strength and top-tier doctors to attract and retain customers. The accelerated expansion plan, combined with like-for-like growth, is expected to position Kaya ahead of the overall market growth in the near future.
Business Mix and Cost Structure
The clinic business is primarily service-driven, with services accounting for 85% of collections and products making up 15%. Within services, skin treatments constitute the majority, followed by hair (5-6%) and body (around 7%). Clinic-level EBITDA is reported at 25-26%, with marketing spend at 10-11% of revenue and corporate costs at 18-20%, bringing overall EBITDA to near breakeven.